Stay tuned
Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
SMC backs first GPRC5D‑targeting bispecific for patients after thre
Alzecure enters collaboration and with Lilly for Alzheimer’s project
Partnership grants Lilly global rights to Alzstatin ACD680 More:
WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
Inclusion on the Pentagon’s 1260H list automatically makes WuXi App
Merck, Gilead score in effort to develop the first weekly HIV pill
A combination of Merck’s islatravir and Gilead’s lenacapavir has
As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals
Merck & Co. and Gilead are pulling the plug on the phase 3 Evoke-
Stay tuned
© 1994 - 2026 B.M. Pharmaceuticals